HealthCare Global Enterprise partners with Accenture for AI-driven cancer care
HealthCare Global Enterprise, one of the largest cancer care networks in India, is teaming up with Accenture to accelerate cancer research and care through the use of advanced technologies, including generative AI and deep learning.
Headquartered in Bengaluru, HealthCare Global Enterprises has a network of 22 cancer centers across India and Africa supporting the diagnosis and treatment of cancer under one roof.
As part of the collaboration with Accenture, HealthCare Global Enterprises will adopt technologies including artificial intelligence, machine learning, generative AI, and quantum computing to enable early detection and treatment for various types of cancer. Key applications include image analysis software, informatics, and novel algorithms to analyze data from cancer patients and study molecular alterations that can have a broader impact on patient care.
Additionally, the initiative aims to enhance the understanding of various cancers, including their development, symptoms, and origins, to enable new treatment algorithms for precision medicine and advance the quality of therapy and care.
The program, according to HealthCare Global Enterprises the first of its kind in South Asia, will leverage Accenture’s AI consulting and technology capabilities, as well as its generative AI studios in Asia.
B. S. Ajaikumar, Executive Chairman at HealthCare Global Enterprises, commented: “Today, optimizing cancer care necessarily calls for tech-driven advancements in research and academics, especially for ensuring seamless, error-free data collection and streaming. Given the heterogenicity of tumor genomics and other forms of omics, AI has become integral to precise, personalized medical advancements.”
“Accenture’s deep expertise in technology and analytics, leveraging AI modeling, will help us enhance our research aimed at developing patient-centric therapies with lasting outcomes. This collaborative initiative is a fitting testament to our stature as a cancer care leader focused on disruptive innovation.”
Speaking about the project the Global Lead of Data and AI at Accenture, Senthil Ramani, said: “Next-gen computing, including generative AI, combined with deep biological and clinical expertise, can play a pivotal role in cancer research and care, addressing needs of patients and benefiting the global healthcare industry at large.”
“Together with HealthCare Global Enterprises, we are blending our global expertise in data and AI along with life sciences R&D to rapidly and accurately improve decision-making for the treatment and care for cancer patients in India, South Asia, and across the world.”
